DNADX
Live / Registered — Registered (as of 17 Sept 2024)
What this means for you
Registered since 17 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79365402
- Registration number
- 7504655
- Mark type
- Stylized text
- Filed
- 06 Feb 2023
- Published for opposition
- 02 Jul 2024
- Registered
- 17 Sept 2024
- Attorney of record
- Donna A. Tobin
Goods and services
- Class 001 — Chemicals: Diagnostic preparations for scientific purposes, in the field of cancer; reagents for research purposes, in the field of cancer; reagents for medical research, in the field of cancer; diagnostic reagents for scientific or research use, in the field of cancer; reagents for scientific or research use in the field of cancer; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, in the field of cancer
- Class 005 — Pharmaceuticals: Diagnostic preparations for medical purposes, in the field of cancer; diagnostic reagents for medical use, in the field of cancer; diagnostic biomarker reagents for medical purposes, in the field of cancer; clinical medical reagents, in the field of cancer; medical diagnostic reagents for use in analysis of circulating tumor DNA extracted from blood samples, for use in the field of cancer; medical diagnostic reagents for use in diagnostic tests, in the field of cancer; biomarkers being copy number alterations and gene mutation for the diagnosis, prognosis and treatment of cancer; medical diagnostic reagents and assays for the diagnosis, prognosis and treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; compounds, namely, chemotherapy drugs, inmunotherapy agents, targeted drug therapies and hormonal therapies for treating cancer; pharmaceutical preparations for use in oncology; biological reagents for medical use, in the field of cancer; diagnostic reagent kits comprised of medical diagnostic reagents and assays for testing body fluids for medical use in the field of cancer.
Owner
Prosecution history
- 15 Mar 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 24 Feb 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 24 Feb 2025 — FINAL DISPOSITION PROCESSED
- 17 Dec 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 17 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 31 Aug 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 14 Aug 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 14 Aug 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 02 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Jul 2024 — PUBLISHED FOR OPPOSITION
- 01 Jul 2024 — NOTIFICATION PROCESSED BY IB
- 12 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Jun 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 11 Jun 2024 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB